Cameroon

Cameroonian child, for article on malaria vaccine rollout

Cameroon’s malaria vaccine cuts child cases 20% in first year

Cameroon’s malaria vaccine rollout delivered something remarkable in its first year: nearly 67,000 fewer malaria cases among children under five across 42 high-burden districts, a 20% drop compared to 2023. The country was one of 13 across Africa to fold the long-awaited vaccine into routine childhood immunization in 2024, part of a coordinated regional push that delivered more than 18 million doses. Among the first to be vaccinated were twins born in January 2024, whose mother says simply that they have never had malaria. After three decades of development and years of pilot studies, a tool once considered out of reach is now protecting children at scale — and the early evidence suggests it is working.

A healthcare worker administering a vaccine to a young child in Africa for an article about malaria vaccine rollout, for article on malaria vaccine rollout

Cameroon launches the world’s first routine malaria vaccine program

Malaria vaccine rollout reached a historic milestone in January 2024 when Cameroon became the first country to administer the RTS,S vaccine, also known as Mosquirix, as part of a routine national immunization program. More than 662,000 doses began reaching children across the country, targeting a disease responsible for 95% of global malaria deaths, most among children under five. The moment caps over 35 years of development and a successful WHO recommendation in 2021. With 19 additional African countries planning to follow, the rollout could eventually protect millions of children each year.

Hand holding a vial and syringe, for article on malaria vaccine rollout

Twelve African countries will receive 18 million doses of the first-ever malaria vaccine

Malaria vaccines are heading to twelve African countries for the first time, with 18 million doses of RTS,S/AS01 set to roll out between 2023 and 2025. Nine nations are introducing the shot into routine childhood immunization, joining Ghana, Kenya, and Malawi, where more than 1.7 million children have already been vaccinated since 2019. The pilot countries have seen severe malaria cases and child deaths decline, and families are showing up eager for their children to be protected. After a century of scientific struggle against one of humanity’s deadliest diseases, this rollout marks a turning point — proof that patient global collaboration can deliver lifesaving tools to the children who need them most.